Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic). - Concepedia

Concepedia

Publication | Closed Access

Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

31

Citations

0

References

2006

Year

Klemens Budde, Greg Knoll, J J Curtis, Lewis Chan, Erich Pohanka, M. Gentil, Yodit Seifu, A. C. Marrast, H. H. Neumayer

Abstract

These data demonstrate that long-term use of EC-MPS is effective and has an acceptable tolerability profile in renal transplant patients, and confirm that conversion of maintenance renal transplant patients from MMF to EC-MPS is a safe therapeutic option.